Video

Dr Roy Beveridge on Physician Reaction to Value-Based Payment Models

The introduction of value-based payment models means that the goals of providing optimal patient care have become aligned for the clinician and the insurer, leading to more cooperation and support, said Roy Beveridge, MD, chief medical officer of Humana. This represents a shift from the more adversarial relationship between physicians and payers that existed under fee-for-service models.

The introduction of value-based payment models means that the goals of providing optimal patient care have become aligned for the clinician and the insurer, leading to more cooperation and support, said Roy Beveridge, MD, chief medical officer of Humana. This represents a shift from the more adversarial relationship between physicians and payers that existed under fee-for-service models.

Transcript (slightly modified)

What has been the physician reaction to the increase in value-based payment models?

Traditionally, fee-for-service physicians have had very negative interactions with their payer, because there’s an adversarial relationship that’s set up in that relationship. When you move to a value relationship, there is a complete alignment between what’s best for the patient is actually what’s really good for the clinician, and the insurer, the payer, becomes a source of support to allow the provider to take care of the patient.

You see that in data, you see that in analytics, you see that in programs. So a small physician group can’t have nurses that go in and take care of their patients for translation services or pharmacy medication programs. That’s where companies like Humana do it and do it really well.

Related Videos
IMS Recap
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
April Armstrong, MD, MPH, chief of dermatology, UCLA
Javed Butler, MD, MPH, MBA
Screenshot during an interview with Aaron Adkisson, PharmD
Kirollos Hanna, PharmD
Binod Dhakal, MD.
Stuart Staggs
Ashraf Badros, MB, ChB.
Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo